While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

A new drug is helping families who've spent years padlocking fridges, chaining garbage cans, and hiding food as their ...

Many focus on what weight-loss drugs take away: pounds. But they also offer patients something new: a sense of agency.

China is a one of the most important regions for the booming obesity market, thanks to government incentives and changing ...

Obesity, diabetes and cardiovascular diseases are increasingly present in the population. Brown adipose tissue has a ...

Eli Lilly's drug, called eloralintide, helped some patients lose more than 11% of their body weight in three months.

An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could eventually be an alternative or add-on to popular GLP-1 medications.

Despite an increase in the prevalence of prescribing, only 0.5% of U.S. adolescents with obesity were prescribed an obesity ...

Eli Lilly's experimental obesity drug, eloralintide, helped some patients lose 11.5% of their body weight at 12 weeks in an ...

A new analysis of obesity guidelines suggests more evidence is needed to develop stronger guidelines for the transition ...

In children with undernutrition, increasing weight in a child’s first decade of life can lead to significantly taller ...

A groundbreaking initiative is taking flight in west Louisville, targeted at combating one of the community's most pressing health issues: childhood obesity.